Loading...
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
BACKGROUND & AIMS: Adverse events (AEs) including reactivation of herpes zoster (HZ) and venous thromboembolism (VTE) have been reported from clinical trials of tofacitinib in ulcerative colitis (UC). We investigated the incidence rates of AEs in a real-world study of UC patients given tofacitin...
Na minha lista:
| Udgivet i: | Clin Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779667/ https://ncbi.nlm.nih.gov/pubmed/32629130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.06.050 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|